TGFBI is also overexpressed in our metastatic discovery set and has been shown to induce epithelial to mesenchymal transition (43) as well as being associated with ccRCC tumor progression and poor prognosis (44). The gene discussed is TGFBI; the disease is nonpapillary renal cell carcinoma.